These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 21750087)

  • 21. Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells.
    Liang X; Moseman EA; Farrar MA; Bachanova V; Weisdorf DJ; Blazar BR; Chen W
    Blood; 2010 Jun; 115(24):5041-52. PubMed ID: 20339095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes.
    Bomben R; Gobessi S; Dal Bo M; Volinia S; Marconi D; Tissino E; Benedetti D; Zucchetto A; Rossi D; Gaidano G; Del Poeta G; Laurenti L; Efremov DG; Gattei V
    Leukemia; 2012 Jul; 26(7):1584-93. PubMed ID: 22343732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toll-like receptors signaling: A complex network for NF-κB activation in B-cell lymphoid malignancies.
    Ntoufa S; Vilia MG; Stamatopoulos K; Ghia P; Muzio M
    Semin Cancer Biol; 2016 Aug; 39():15-25. PubMed ID: 27402288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells.
    Bourke E; Bosisio D; Golay J; Polentarutti N; Mantovani A
    Blood; 2003 Aug; 102(3):956-63. PubMed ID: 12689944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Constitutive activation of NF-κB signaling by NOTCH1 mutations in chronic lymphocytic leukemia.
    Xu ZS; Zhang JS; Zhang JY; Wu SQ; Xiong DL; Chen HJ; Chen ZZ; Zhan R
    Oncol Rep; 2015 Apr; 33(4):1609-14. PubMed ID: 25633905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation profiles.
    Kanduri M; Marincevic M; Halldórsdóttir AM; Mansouri L; Junevik K; Ntoufa S; Kultima HG; Isaksson A; Juliusson G; Andersson PO; Ehrencrona H; Stamatopoulos K; Rosenquist R
    Epigenetics; 2012 Dec; 7(12):1435-42. PubMed ID: 23154584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SLP76 integrates into the B-cell receptor signaling cascade in chronic lymphocytic leukemia cells and is associated with an aggressive disease course.
    Dezorella N; Katz BZ; Shapiro M; Polliack A; Perry C; Herishanu Y
    Haematologica; 2016 Dec; 101(12):1553-1562. PubMed ID: 27443285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of functional toll-like receptors by B-chronic lymphocytic leukemia cells.
    Grandjenette C; Kennel A; Faure GC; Béné MC; Feugier P
    Haematologica; 2007 Sep; 92(9):1279-81. PubMed ID: 17768129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2.
    Schulz A; Toedt G; Zenz T; Stilgenbauer S; Lichter P; Seiffert M
    Haematologica; 2011 Mar; 96(3):408-16. PubMed ID: 21134984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profiling B cell chronic lymphocytic leukemia by reverse phase protein array: Focus on apoptotic proteins.
    Frezzato F; Accordi B; Trimarco V; Gattazzo C; Martini V; Milani G; Bresolin S; Severin F; Visentin A; Basso G; Semenzato G; Trentin L
    J Leukoc Biol; 2016 Nov; 100(5):1061-1070. PubMed ID: 27312846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TLR9 signaling defines distinct prognostic subsets in CLL.
    Efremov DG; Bomben R; Gobessi S; Gattei V
    Front Biosci (Landmark Ed); 2013 Jan; 18(1):371-86. PubMed ID: 23276930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia.
    Adinolfi E; Melchiorri L; Falzoni S; Chiozzi P; Morelli A; Tieghi A; Cuneo A; Castoldi G; Di Virgilio F; Baricordi OR
    Blood; 2002 Jan; 99(2):706-8. PubMed ID: 11781259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toll-like receptor stimulation in splenic marginal zone lymphoma can modulate cell signaling, activation and proliferation.
    Fonte E; Agathangelidis A; Reverberi D; Ntoufa S; Scarfò L; Ranghetti P; Cutrona G; Tedeschi A; Xochelli A; Caligaris-Cappio F; Ponzoni M; Belessi C; Davis Z; Piris MA; Oscier D; Ghia P; Stamatopoulos K; Muzio M
    Haematologica; 2015 Nov; 100(11):1460-8. PubMed ID: 26294727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of
    Plešingerová H; Janovská P; Mishra A; Smyčková L; Poppová L; Libra A; Plevová K; Ovesná P; Radová L; Doubek M; Pavlová Š; Pospíšilová Š; Bryja V
    Haematologica; 2018 Feb; 103(2):313-324. PubMed ID: 29122990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein expression analysis of chronic lymphocytic leukemia defines the effect of genetic aberrations and uncovers a correlation of CDK4, P27 and P53 with hierarchical risk.
    Winkler D; Schneider C; Zucknick M; Bögelein D; Schulze K; Zenz T; Mohr J; Philippen A; Huber H; Bühler A; Habermann A; Benner A; Döhner H; Stilgenbauer S; Mertens D
    Haematologica; 2010 Nov; 95(11):1880-8. PubMed ID: 20713460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraclonal cell expansion and selection driven by B cell receptor in chronic lymphocytic leukemia.
    Colombo M; Cutrona G; Reverberi D; Fabris S; Neri A; Fabbi M; Quintana G; Quarta G; Ghiotto F; Fais F; Ferrarini M
    Mol Med; 2011; 17(7-8):834-9. PubMed ID: 21541442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of functional sphingosine-1 phosphate receptor-1 is reduced by B cell receptor signaling and increased by inhibition of PI3 kinase δ but not SYK or BTK in chronic lymphocytic leukemia cells.
    Till KJ; Pettitt AR; Slupsky JR
    J Immunol; 2015 Mar; 194(5):2439-46. PubMed ID: 25632006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals.
    Gutiérrez NC; Ocio EM; de Las Rivas J; Maiso P; Delgado M; Fermiñán E; Arcos MJ; Sánchez ML; Hernández JM; San Miguel JF
    Leukemia; 2007 Mar; 21(3):541-9. PubMed ID: 17252022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.
    Morabito F; Mosca L; Cutrona G; Agnelli L; Tuana G; Ferracin M; Zagatti B; Lionetti M; Fabris S; Maura F; Matis S; Gentile M; Vigna E; Colombo M; Massucco C; Recchia AG; Bossio S; De Stefano L; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Tassone P; Negrini M; Monti S; Rossi D; Gaidano G; Ferrarini M; Neri A
    Clin Cancer Res; 2013 Nov; 19(21):5890-900. PubMed ID: 24036852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors.
    Marincevic M; Mansouri M; Kanduri M; Isaksson A; Göransson H; Smedby KE; Jurlander J; Juliusson G; Davi F; Stamatopoulos K; Rosenquist R
    Haematologica; 2010 Dec; 95(12):2072-9. PubMed ID: 20801898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.